While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...

As of 2021–2022, approximately 74% of U.S. adults aged 20 and older were classified as overweight or obese, with 42.1% ...

According to leaders in obesity and nutrition research, following these key nutrition guidelines will make the most of GLP-1 ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

GLP-1 is a hormone released in the gut after meals ... Increasing GLP-1 levels can be beneficial for managing type 2 diabetes and weight. Consuming a nutritious diet containing foods like whole ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...